Extended Follow-up of Women Who Received One, Two, and Three Doses of the HPV Vaccine in the Costa Rica Vaccine Trial (CVT), ESCUDDO-CVT Study
National Cancer Institute (NCI)
National Cancer Institute (NCI)
UNC Lineberger Comprehensive Cancer Center
National Cancer Institute (NCI)
Yuzuncu Yil University
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
Johns Hopkins Bloomberg School of Public Health
University of Utah
Merck Sharp & Dohme LLC
University Hospital, Brest
Eastern Cooperative Oncology Group
University of Pennsylvania
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
The Institute of Molecular and Translational Medicine, Czech Republic
University of Utah
University of Miami
Roswell Park Cancer Institute
Basic Health International, Inc.
National Institutes of Health Clinical Center (CC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Washington University School of Medicine
National Cancer Institute (NCI)
KTO Karatay University
UNC Lineberger Comprehensive Cancer Center
Columbia University
Institut d'Investigació Biomèdica de Bellvitge
University of California, Irvine
Queen Mary University of London
Kahramanmaras Sutcu Imam University
Antiva Biosciences
University of Maryland, Baltimore
National Cancer Institute (NCI)
The Institute of Molecular and Translational Medicine, Czech Republic
The Institute of Molecular and Translational Medicine, Czech Republic
Institut d'Investigació Biomèdica de Bellvitge
Mayo Clinic
Merck Sharp & Dohme LLC
Qurasense
Liaquat University of Medical & Health Sciences
Boston Medical Center
Baylor College of Medicine
University Hospital Tuebingen
Weill Medical College of Cornell University
National Vaccine and Serum Institute, China
Ufuk University
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
University Hospital, Geneva
National Vaccine and Serum Institute, China
Assistance Publique - Hôpitaux de Paris